Company Filing History:
Years Active: 2009
Title: Yves Fouron: Innovator in Immunostimulatory Nucleic Acids
Introduction
Yves Fouron is a notable inventor based in Marlboro, MA (US). He has made significant contributions to the field of immunology, particularly in the treatment of asthma and allergies. His innovative approach combines immunostimulatory nucleic acids with existing medicaments to enhance therapeutic outcomes.
Latest Patents
Yves Fouron holds a patent for "Immunostimulatory nucleic acids for the treatment of asthma and allergy." This invention involves the administration of an immunostimulatory nucleic acid, either alone or in combination with an asthma/allergy medicament. The goal is to treat or prevent asthma and allergy in subjects. The combination of drugs is administered in synergistic amounts, varying dosages, or at different time schedules. Additionally, the invention includes kits and compositions related to these drug combinations.
Career Highlights
Yves Fouron is associated with Coley Pharmaceutical Group, Inc., where he has been instrumental in advancing research and development in immunotherapy. His work has the potential to significantly impact the treatment landscape for asthma and allergies.
Collaborations
Throughout his career, Yves has collaborated with esteemed colleagues, including Robert L. Bratzler and Deanna M. Petersen. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Yves Fouron is a pioneering inventor whose work in immunostimulatory nucleic acids represents a significant advancement in the treatment of asthma and allergies. His contributions continue to shape the future of immunotherapy.